Raymond James sets USD 39.00 target for Acadia Healthcare stock
Published on 10/15/2026 at 19:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst view and scheduled results
- Raymond James set a USD 39.00 target on September 28, 2026.
- Second-quarter revenue reached USD 865.84 million for the period ended June 30, 2026.
- Acadia Healthcare stock costs EUR 27.90 at Lang & Schwarz on October 15, 2026 at 7:09 p.m. CEST.
- Acadia Healthcare will release third-quarter results on November 4, 2026.
Raymond James initiated coverage of Acadia Healthcare with an Outperform rating and a USD 39.00 price target on September 28, 2026. Against the USD 31.22 Nasdaq price at 1:17 p.m. ET on October 15, 2026, that target implies 24.92 percent upside. The stock was trading at EUR 27.90 at Lang & Schwarz on October 15, 2026 at 7:09 p.m. CEST.
Revenue sets the operating base
Acadia reported second-quarter revenue of USD 865.84 million for the period ended June 30, 2026, compared with adjusted earnings of USD 0.38 per share against a USD 0.36 consensus estimate, according to Investing.com. The revenue figure was 2.58 percent above the cited USD 844.1 million expectation.
Stock stays below the yearly high
The USD 31.22 Nasdaq price stood 12.87 percent below Acadia's USD 35.83 52-week high and 173.14 percent above its USD 11.43 low on October 15, 2026. Finance data also put the company at a USD 2.9 billion market capitalization, while its average volume was 1,906,518 shares and the latest volume was 609,207 shares.
Valuation and next reporting date
Raymond James cited professional liability uncertainty as a near-term constraint in its September 28, 2026 coverage. Acadia operates 279 behavioral healthcare facilities with approximately 12,600 beds in 40 states and Puerto Rico, according to Business Wire. The company will publish third-quarter 2026 results after the market close on November 4, 2026, followed by a conference call on November 5, 2026 at 9:00 a.m. ET.
Comparison with peers
Acadia Healthcare (Nasdaq, USD): minus 1.42 percent, market capitalization USD 2.9 billion
HCA Healthcare (NYSE, USD): minus 0.45 percent, P/E 15.68, market capitalization USD 101.4 billion
Universal Health Services (NYSE, USD): plus 1.00 percent, P/E 7.70, market capitalization USD 11.1 billion
Price and trading perspective
Acadia's Nasdaq quotation and its euro quotation point to the same listed company, but the two prices use different currencies and venues. The more immediate investor markers are the distance from the USD 35.83 yearly high, the USD 39.00 Raymond James target, and the November 4 reporting date.
Acadia Healthcare was trading at EUR 27.90 at Lang & Schwarz on October 15, 2026 at 7:09 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Acadia Healthcare stock.
Acadia Healthcare stock at a glance
- Company: Acadia Healthcare Company, Inc.
- ISIN: US00404A1097
- WKN: A1JNMF
- Ticker: ACHC
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 15, 2026, 7:09 p.m. CEST): EUR 27.90
- Market capitalization: USD 2.9 billion (as of October 15, 2026)
- 52-week range: USD 11.43-35.83 (as of October 15, 2026)
- Sector / Industry: Healthcare / behavioral healthcare
- Next earnings date: November 4, 2026
Market context: Market report S&P 500.
